2024-09-24
A team at NUS Medicine has developed a groundbreaking nanoparticle technology that can diagnose atherosclerosis, target atherosclerotic plaques, and deliver therapeutic agents directly to inhibit the progression of atherosclerosis in the preclinical models.
